Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 318-321

  Choe, Kevin S ^a   Salama, Joseph K ^b   Stenson, Kerstin M ^c   Blair, Elizabeth A ^c   Witt, Mary Ellyn ^c   Cohen, Ezra E W ^c   Haraf, Daniel J ^c   Vokes, Everett E ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemoradiotherapy; Head and neck cancer; Induction chemotherapy; Postoperative radiotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; METASTASIS; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 78149357610     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.003     Document Type: Article

References (21)

1. T.Y. Seiwert, and E.E. Cohen State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 2005 1341 1348
2. D.T. Huang, C.R. Johnson, and R. Schmidt-Ullrich Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study Int J Radiat Oncol Biol Phys 23 1992 737 742
3. G.B. Snow, A.A. Annyas, and E.A. van Slooten Prognostic factors of neck node metastasis Clin Otolaryngol Allied Sci 7 1982 185 192
4. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
5. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
6. J. Bernier, J.S. Cooper, and T.F. Pajak Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27 2005 843 850
7. R. Hitt, A. Grau, and A. Lopez-Pousa Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) verus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer J Clin Oncol 27 2009 Abstract 6009
8. A. Paccagnella, H. Buffoli, and A. Koussis Concomitant chemoradiotherapy (CT/RT) vs neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil (TPF) followed by CT/RT in locally advanced head and neck cancer. Final results of a phase II randomized study J Clin Oncol 26 2008 Abstract 6000
9. C. Domenge, C. Hill, and J.L. Lefebvre Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC) Br J Cancer 83 2000 1594 1598
10. A. Paccagnella, A. Orlando, and C. Marchiori Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 86 1994 265 272
11. P.L. Zorat, A. Paccagnella, and G. Cavaniglia Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up J Natl Cancer Inst 96 2004 1714 1717
12. M.S. Kies, D.J. Haraf, and F. Rosen Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer J Clin Oncol 19 2001 1961 1969
13. F.R. Rosen, D.J. Haraf, and M.S. Kies Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer Clin Cancer Res 9 2003 1689 1697
14. J.K. Salama, K.M. Stenson, and E.O. Kistner Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels Ann Oncol 19 2008 1787 1794
15. J.K. Salama, T.Y. Seiwert, and E.E. Vokes Chemoradiotherapy for locally advanced head and neck cancer J Clin Oncol 25 2007 4118 4126
16. L.F. Licitra, F. Perrone, and E. Tamborini Effect of antityrosyne kinase agents on in vitro tumor cell proliferation induced by wound drainage fluids (WDFs) of head and neck cancer (HNSCC) patients J Clin Oncol 26 2008 Abstract 6077
17. K.K. Ang, A. Trotti, and B.W. Brown Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 51 2001 571 578
18. L.J. Peters, H. Goepfert, and K.K. Ang Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial Int J Radiat Oncol Biol Phys 26 1993 3 11
19. G.E. Laramore, C.B. Scott, and M. al-Sarraf Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034 Int J Radiat Oncol Biol Phys 23 1992 705 713
20. D.I. Rosenthal, J. Harris, and A.A. Forastiere Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024 J Clin Oncol 27 2009 4727 4732
21. C.P. Belani, J. Barstis, and M.C. Perry Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation J Clin Oncol 21 2003 2933 2939